Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/IIa study of BG136 in advanced melanoma
CTR20251215Phase 2Terminated
- Sponsor
- Qingdao Marine Biomedical Research Institute
- Start
- Apr 2025
- Countries
- 1
01
Overview
A Phase 2 trial of BG136 in melanoma, sponsored by Qingdao Marine Biomedical Research Institute. Started Apr 2025; status: terminated.
02
Drugs
BG136
03
Conditions
melanoma
Beyond the preview
Go deeper on CTR20251215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251215.